Librela (bedinvetmab) is a 15mg injectable veterinary solution specifically designed for dogs weighing 20.1-30.0 kg. It is used to treat pain associated with osteoarthritis in dogs 12 months of age or older. Each package contains 1 vial of 1mL solution manufactured by Zoetis Belgium SA. Key features: • Injectable solution for dogs • Treats osteoarthritis pain • For dogs 20.1-30.0 kg • 15mg strength per vial • 1mL vial size • For dogs 12+ months old • Manufactured by Zoetis Librela represents an innovative treatment option for canine osteoarthritis pain management. The active ingredient bedinvetmab is a monoclonal antibody specifically developed for veterinary use. The medication should be administered by a veterinary professional through injection. The product requires proper storage conditions and handling as specified by the manufacturer. Only for veterinary use and requires prescription.